Type-1 Diabetes Treatment Market: Dynamics, Segments, Size, and Demand Analysis during 2021-2025 | Impact of COVID-19 Pandemic

Market Synopsis

The Global Type-1 Diabetes Treatment Market is expected to cross USD 9.6 billion by 2025 at a CAGR of 7.9%.According to the Lancet, type-1 diabetes accounts for 5%–10% of all diabetes cases worldwide. Failure to produce insulin is the cause of this type of diabetes. The onset of the disease may be at a young age or exacerbated by aging and lifestyle, and management requires lifelong medication. Increasing access to medication and rising awareness about the condition are fueling the growth of the market.

Download Sample of This Strategic Report- https://www.kennethresearch.com/sample-request-10159217

Market USP

Lifelong reliance on medication to manage the condition along with the rising prevalence of the disease.

Market Drivers

Rising prevalence of type-1 diabetes due to environmental and genetic factors

Growing geriatric population, which is susceptible to type-1 diabetes.

Increasing prevalence of obesity, which is a contributing factor

Rising worldwide spending on healthcare

Growing access to medication worldwide

Improved diagnostic capabilities ensuring early detection

Government support for the treatment of type-1 diabetes

Market Restraints

Negative side effects of the medication

Stringent approvals process that varies from nation to nation


By Product

Rapid-Acting Insulin: The largest and fastest-growing market in this segment. The segment has been further divided into Admelog, Humalog, Novolog, and others.

Short-Acting Insulin: Effective for 3–6 hours. Further divided into

Medium-Acting Insulin: Effective for 12–18 hours.

Long-Acting Insulin: Used for chronic cases and is effective for upwards of 24 hours. The segment has been further divided into Lantus, Levemir, and others.

Others: Ultra long-term action insulin and inhaled insulin are covered in this segment.

By End User

Hospitals and Clinics: Expected to be the largest and fastest-growing market during the forecast period.

Specialty Centers: Catering exclusively to patients suffering from diabetes, these centers are being opened across the globe.

Others: Treatment at home and at old age homes are covered in this segment.

Download Sample of This Strategic Report- https://www.kennethresearch.com/sample-request-10159217

By Region




Middle East & Africa

Regional Analysis

Americas: Expected to be the largest market during the forecast period.

Europe: A growing market.

Asia-Pacific: The fastest-growing market.

Middle East & Africa: The smallest market but with a very high number of cases.

Request For Full Report- https://www.kennethresearch.com/sample-request-10159217

Key Players

Astellas Pharma (Japan)

Eli Lilly (US)

Merck (US)

Novo Nordisk (Denmark)

Sanofi (France)

AstraZeneca (UK)

Boehringer Ingelheim GmbH (Germany)

Novartis (Switzerland)

Pfizer Inc. (US)

Abbott Laboratories (US)

Mannkind Corporation (US)

Braun Melsungen AG (Germany)

Macrogenics, Inc. (US)

DiaVacs, Inc. (US)

Biodel, Inc. (US)

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.

Contact Us

Kenneth Research
Email: Sales@kennethresearch.com
Phone: +1 313 462 0609

James Bullock is a Research Expert with a demonstrated history of working in the professional training & coaching industry. Strong professional skilled in business strategy , Strategic Planning, Research Strategy, and Marketing. also have interest in new innovations and technology

Leave a Reply